Acrivon Therapeutics, Inc. (ACRV)

1.83 +0.13 (+7.65%) USD  |  NASDAQ  |  Jan 14, 16:00
1.82 -0.01 (-0.55%) Pre-Market: 08:33
More

Acrivon Therapeutics EV to CFO

EV to CFO Chart

View EV to CFO for ACRV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to CFO Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to CFO Range, Past 5 Years

View EV to CFO Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to CFO Benchmarks

View EV to CFO Benchmarks
Start Trial
Aclarion, Inc. Upgrade
Vistagen Therapeutics, Inc. Upgrade
Spero Therapeutics, Inc. Upgrade
Humacyte, Inc. Upgrade
PMGC Holdings, Inc. Upgrade

EV to CFO Related Metrics

EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade